Intravitreal Anti–Vascular Endothelial Growth Factor Therapy and Retinal Nerve Fiber Layer Loss in Eyes With Age-Related Macular Degeneration: A Meta-Analysis | Zendy

Hyun Jin Shin | Zendy; SooNyung Kim | Zendy; Hyewon Chung | Zendy; TaeEun Kim | Zendy; Hyung Chan Kim | Zendy

Open Access

Intravitreal Anti–Vascular Endothelial Growth Factor Therapy and Retinal Nerve Fiber Layer Loss in Eyes With Age-Related Macular Degeneration: A Meta-Analysis

Author(s) -

Hyun Jin Shin,

SooNyung Kim,

Hyewon Chung,

TaeEun Kim,

Hyung Chan Kim

Publication year - 2016

Publication title -

investigative ophthalmology and visual science

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.935

H-Index - 218

eISSN - 1552-5783

pISSN - 0146-0404

DOI - 10.1167/iovs.15-18404

Subject(s) - medicine , nerve fiber layer , ophthalmology , macular degeneration , confidence interval , retinal , meta analysis , bevacizumab , vascular endothelial growth factor , subgroup analysis , randomized controlled trial , surgery , vegf receptors , chemotherapy

Clinical study findings regarding the association between repeated injections of intravitreal anti-vascular endothelial growth factor (VEGF) and the risk of retinal nerve fiber layer (RNFL) thinning in patients with age-related macular degeneration (AMD) have been inconsistent. We investigated this association by using a meta-analysis.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research